GAB2 and melanoma: Notably, only 1 nonmyeloid human cell line in the DepMap was affected by GAB2 knockout (YUHOIN melanoma cells), suggesting that GAB2 inactivation may be tolerated in most cells; this is consistent with published results from mouse models, in which germline Gab2 knockouts are viable, with normal resting blood counts (44, 45).